ESC Premium Access

Prognostic impact of suspected cardiac amyloidosis in aortic stenosis patients referred for transcatheter aortic valve implantation

Congress Presentation

About the speaker

Doctor Vera Ferreira

Hospital de Santa Marta, Lisbon (Portugal)
1 follower

6 more presentations in this session

Hereditary transthyretin amyloidosis: predictors of conduction disease

Speaker: Doctor A. Dias De Frias (Porto, PT)


High-sensitivity cardiac troponin T and NT-proBNP for ruling-in and ruling-out of cardiac amyloidosis

Speaker: Doctor V. Castiglione (Pisa, IT)


Regional cardiac uptake of 99-Tc-DPD is a novel powerful and independent prognostic marker in cardiac ATTR wild type amyloidosis.

Speaker: Doctor P. Milani (Pavia, IT)


Benefits of tafamidis in patients with advanced transthyretin amyloid cardiomyopathy

Speaker: Doctor C. Rapezzi (Ferrara, IT)


Quantitative and functional evaluation of endothelial progenitor cells in patients with cardiac amyloidosis

Speaker: Doctor O. Itzhaki Ben Zadok (Petah Tikva, IL)


Access the full session

Advances in the Diagnosis and Treatment of Cardiac Amyloidosis

Speakers: Doctor V. Ferreira, Doctor A. Dias De Frias, Doctor V. Castiglione, Doctor P. Milani, Doctor C. Rapezzi...

About the event


ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb